Oscotec Inc.

Notice Press Releases Publications IR Materials

List of Articles
Date	Site	Media	Pipeline
2007-02-19	Profiles of Four New Stock-Billionaires	MBN	Oscotec
2019-11-04	AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications	Molecular Cancer	SKI-G-801
2019-12-02	"Global Immune Thrombocytopenia (ITP) Market Insights, Epidemiology, and Forecasts, 2017-2028 : Focus on United States, Germany, Spain, Italy, France, and the United Kingdom, and Japan"	PRNewswire	Genosco
2014-04-03	G-749, a novel FLT3 Kinase inhibitor, can overcome drug resistance for the treatment of acute myeloid leukemia.	PubMed	SKI-G-801
2016-01-19	Oscotec`s SYK inhibitor Program Gets Korea Drug Fund Money	Scrip (Informa Pharma Intelligence)	SYK-O-703
2016-08-23	INTERVIEW: Oscotec Lays Out Global Ambitions For RA, Cancer Drugs	Scrip (Informa Pharma Intelligence)	Oscotec
2019-12-14	Lazertinib Shows Promising Antitumor Activity in Patients With EGFR+ NSCLC	Targeted Oncology	Lazertinib
2018-06-11	Yuhan ups investment in biotechs for immuno-oncology drug push	THE INVESTOR	Yuhan/Lazertinib
2019-01-28	Genosco gears up for IPO	THE INVESTOR	Genosco
2007-02-20	IPOs spawn instant billionaires	The Korea Herald	Oscotec
2018-03-14	More than half of Korean biopharma firms view R&D investments as assets.	The Korea Herald	Industry
2019-11-04	Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1-2 study	THE LANCET ONCOLOGY	Lazertinib

To inquire